Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9512730rdf:typepubmed:Citationlld:pubmed
pubmed-article:9512730lifeskim:mentionsumls-concept:C0006675lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0032458lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0019868lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:9512730lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:9512730pubmed:issue1lld:pubmed
pubmed-article:9512730pubmed:dateCreated1998-4-16lld:pubmed
pubmed-article:9512730pubmed:abstractTextPrevious studies performed in this laboratory have shown that certain benzo(a)pyrene (BaP) metabolites, such as benzo(a)pyrene-7,8-dihydrodiol (BaP-7,8-diol) and benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE), were more effective in elevating intracellular Ca2+ in normal human peripheral blood mononuclear cell (HPBMC) T and B cells than was BaP. Additionally, it has been shown that the suppression of human T cell mitogenesis produced by polycyclic aromatic hydrocarbons (PAHs) and certain BaP metabolites is reversed by treatment with alpha-naphthoflavone (ANF), a cytochrome P450 1A and 1B inhibitor. ANF also diminishes the elevation in intracellular calcium (Ca2+) produced by BaP in HPBMC. In the present studies, we further defined the relationships between intracellular Ca2+ elevation produced by BaP and two immunotoxic P450-derived metabolites, BaP-7,8-diol and BPDE in the Daudi human B cell line. At 1, 4, and 18 h, both BaP-7,8-diol and BPDE produced a significant rise in intracellular Ca2+. This effect, however, was not observed with BaP or benzo(e)pyrene (BeP), a nonimmunotoxic PAH. To evaluate the potential role of cytochrome P450 metabolism in PAH-induced Ca2+ elevation, Daudi cells were pretreated with ANF for 4 h, followed by treatment with BaP metabolites for 18 h. ANF completely reversed the rise in Ca2+ produced by BaP-7,8-diol, but had no effect on the Ca2+ elevation produced by BPDE. These results suggest that BPDE may be the ultimate P450 metabolite responsible for Ca2+ elevation in human B cells. BaP-7,8-diol and BPDE were found to increase tyrosine phosphorylation in Daudi whole cell lysates and to increase tyrosine phosphorylation of two important Src-related protein tyrosine kinases (PTKs), Lyn and Syk. Inhibition of tyrosine phosphorylation by herbimycin A was found to largely prevent the increase in intracellular Ca2+ produced by BaP-7,8-diol and BPDE, suggesting that Ca2+ elevation is coupled to increased tyrosine phosphorylation in Daudi. BPDE was found to produce a statistically significant increase in tyrosine phosphorylation of Lyn and Syk within 10 min of exposure. Collectively, these data demonstrate that certain P450-derived metabolites of BaP may be responsible for PTK activation and an increase intracellular Ca2+, which may alter antigen receptor signaling in human B cells.lld:pubmed
pubmed-article:9512730pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:languageenglld:pubmed
pubmed-article:9512730pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:citationSubsetIMlld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9512730pubmed:statusMEDLINElld:pubmed
pubmed-article:9512730pubmed:monthMarlld:pubmed
pubmed-article:9512730pubmed:issn0041-008Xlld:pubmed
pubmed-article:9512730pubmed:authorpubmed-author:BurchielS WSWlld:pubmed
pubmed-article:9512730pubmed:authorpubmed-author:MounhoB JBJlld:pubmed
pubmed-article:9512730pubmed:issnTypePrintlld:pubmed
pubmed-article:9512730pubmed:volume149lld:pubmed
pubmed-article:9512730pubmed:ownerNLMlld:pubmed
pubmed-article:9512730pubmed:authorsCompleteYlld:pubmed
pubmed-article:9512730pubmed:pagination80-9lld:pubmed
pubmed-article:9512730pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:meshHeadingpubmed-meshheading:9512730-...lld:pubmed
pubmed-article:9512730pubmed:year1998lld:pubmed
pubmed-article:9512730pubmed:articleTitleAlterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation.lld:pubmed
pubmed-article:9512730pubmed:affiliationUniversity of New Mexico College of Pharmacy, Toxicology Program, Albuquerque 87131-1066, USA.lld:pubmed
pubmed-article:9512730pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9512730pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9512730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9512730lld:pubmed